Discontinued — last reported Q4 '21
CRH Short-Term Borrowings decreased by 7.5% to $111.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from $93.00M to $111.00M. Over 3 years (FY 2022 to FY 2025), Short-Term Borrowings shows an upward trend with a 8.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $94.00M | $156.00M | $162.00M | $173.00M | $107.00M | $118.00M | $159.00M | $153.00M | $117.00M | $93.00M | $107.00M | $123.00M | $120.00M | $111.00M |
| QoQ Change | — | +66.0% | +3.8% | +6.8% | -38.2% | +10.3% | +34.7% | -3.8% | -23.5% | -20.5% | +15.1% | +15.0% | -2.4% | -7.5% |
| YoY Change | — | — | — | — | +13.8% | -24.4% | -1.9% | -11.6% | +9.3% | -21.2% | -32.7% | -19.6% | +2.6% | +19.4% |